Physician profile
Jacob Alexander
NPI 1184082901
$1,998.83
in general payments reported to CMS, 2019-2025
13 companies · $768 in 2025
The $768 reported for 2025 was more than what 98% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $123 · 2022: $261 · 2023: $447 · 2024: $400 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,615.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $606.57 | 2021-2025 | Entyvio |
| Abbvie INC. | $415.19 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $252.34 | 2021-2024 | Dificid |
| Regeneron Healthcare Solutions, INC. | $199.20 | 2022-2025 | Dupixent |
| Lilly USA, LLC | $152.78 | 2025 | Omvoh |
| Janssen Biotech, INC. | $120.21 | 2025 | Tremfya, Simponi, Simponi Aria |
| Ironwood Pharmaceuticals, INC | $90.33 | 2022-2023 | Linzess |
| Madrigal Pharmaceuticals | $57.37 | 2025 | Rezdiffra |
| Conmed Corporation | $36.54 | 2025 | Conmed Generators |
| Micro-Tech Endoscopy USA, INC. | $25.05 | 2021 | |
| Boston Scientific Corporation | $18.21 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.06 | 2023 | Xifaxan |
| Medtronic, INC. | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.